Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
18.12
-0.24 (-1.31%)
Feb 20, 2026, 4:00 PM EST - Market closed
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $3.35 billion as of February 23, 2026. Its market cap has decreased by -51.70% in one year.
Market Cap
3.35B
Enterprise Value
2.76B
1-Year Change
-51.70%
Ranking
Category
Stock Price
$18.12
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from $4.79B to $3.35B, a decrease of -30.08%. That is a compound annual growth rate of -6.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 3.35B | -16.65% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcellx | 3.71B |
| Corcept Therapeutics | 3.66B |
| Ligand Pharmaceuticals | 3.62B |
| Viking Therapeutics | 3.59B |
| Centessa Pharmaceuticals | 3.58B |
| Alumis | 3.49B |
| Spyre Therapeutics | 3.39B |
| Xenon Pharmaceuticals | 3.26B |